Researchers continue to excited about the medication , a novel dual treatment showing remarkable data in initial trials for body loss . It acts by modulating both systems: GLP-1 and GIP, which , when https://larissapjun357359.sharebyblog.com/40657807/a-new-possibility-for-size-reduction